References
- National Heart, Lung and Blood Institute. Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014. Guide to Recommendations. US Department of Health and Human Resources, National Institutes of Health, National Heart, Lung and Blood Institute. https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease
- Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000;342(25):1855–1865.
- Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84(2):643–649.
- Jain S, Bakshi N, Krishnamurti L. Acute chest syndrome in children with sickle cell disease. Pediatr Allergy Immunol Pulmonol. 2017;30(4):191–201.
- Howard J, Hart N, Roberts-Harewood M, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169(4):492–505.
- Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359(21):2254–2265.
- Gillett DS, Gunning KE, Sawicka EH, et al. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation. Br Med J (Clin Res Ed). 1987;294(6564):81–82. http://www.ncbi.nlm.nih.gov/pubmed/3105665; accessed February 25, 2019).
- Chambers J, Smith N, Sehring M, et al. Acute chest syndrome progressing to ARDS in a patient of 25-week gestation. Case Rep Crit Care. 2018;2018:1–3. (eCollection).
- Al-Sawaf O, Köhler P, Eichenauer DA, et al. Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation. Ann Hematol. 2019;98(3):789–791.
- Sewaralthahab SS, Menaker J, Law JY. Successful use of veno-venous extracorporeal membrane oxygenation in an adult patient with sickle cell anemia and severe acute chest syndrome. Hemoglobin. 2018;42(1):65–67.
- ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Taylor Thompson B, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
- Ballas SK, Lieff S, Benjamin LJ, et al.; Investigators, Comprehensive Sickle Cell Centers. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6–13.
- Scheunemann LP, Ataga KI. Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci. 2010;339(3):266–269.
- O'Suoji C, Liem RI, Mack AK, et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer. 2013;60(9):1487–1491.
- Davis BA, Allard S, Qureshi A, et al.; British Society for Haematology. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol. 2017;176(2):192–209.
- Fartoukh M, Lefort Y, Habibi A, et al. Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study. Intensive Care Med. 2010;36(8):1355–1362.
- Makdisi G, Wang I-W. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015;7(7):E166–E176.
- Mateen FJ, Muralidharan R, Shinohara RT, et al. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68(12):1543–1549.
- Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators; Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–1895.
- Boissier F, Bagate F, Schmidt M, et al. Extracorporeal life support for severe acute chest syndrome in adult sickle cell disease: a preliminary report. Crit Care Med. 2019;47(3):e263–e265.